Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Jun 15, 2024 5:14pm
66 Views
Post# 36090745

RE:RE:Way off topic, but why not.l

RE:RE:Way off topic, but why not.lIn response to Trump Cultist Peladawn who stated that "Trump admin had regulations in place and incentives that promoted the sale of trillion of cubic feet of LNG to Europe" .. the New Yorker exposes this degree of Trump / Putin corruption in their comprehensive report entitled "Putin's Shadow Cabinet" which also stated that:

In March, 2014, the Obama Administration imposed sanctions on Russia for its interference in Ukraine; it included Arkady and Boris Rotenberg on its list of sanctioned individuals. The Treasury Department identified the brothers as “members of the Russian leadership’s inner circle,” who “provided support to Putin’s pet projects by receiving and executing high-price contracts for the Sochi Olympic Games and state-controlled Gazprom.” 

Overpricing, usury, and corruption were what the Trump administration was planning on implementing.


https://www.newyorker.com/magazine/2017/05/29/putins-shadow-cabinet-and-the-bridge-to-crimea  
<< Previous
Bullboard Posts
Next >>